Paul Chang is an experienced finance professional currently serving as an Analyst at Sofinnova Investments since May 2025, focusing on long/short public equities. Prior to this role, Paul worked as an Associate at TPG from July 2023 to May 2025, specializing in TPG Growth within the healthcare sector. Paul gained foundational experience as an Investment Banking Analyst at Goldman Sachs, where the focus was on classic healthcare from February 2022 to July 2023, and at Guggenheim Partners in the biopharma healthcare sector from July 2021 to February 2022. Educational credentials include a Bachelor’s degree in Finance and English Literature from NYU Stern School of Business (2017 - 2021), along with attending UNSW in 2020 and graduating from East Lyme High School with a diploma in 2017.
This person is not in any teams
This person is not in any offices